ישראל - עברית - Ministry of Health

rafa laboratories ltd - potassium citrate 0.43 g / 5 ml; potassium gluconate 1.4 g / 5 ml - solution (oral) - combinations - prevention and treatment of hypokalemia.

ישראל - עברית - Ministry of Health

kamada ltd - heparin as sodium 100 iu/ml - solution for injection - heparin - to maintain patency of an indwelling intravenous catheter designed for intermittent injection or blood sampling.

ישראל - עברית - Ministry of Health

medic trim healthcare ltd - heparin sodium 5000 iu/ml - solution for injection - heparin - anticoagulant, treatment of arterial and venous thrombosis, prevention of thromo-embolic complications after surgery.

ישראל - עברית - Ministry of Health

kamada ltd - heparin as sodium 10 iu/ml - solution for injection - heparin - intended to maintain potency of indweling i.v. catheter designed for intermittent injection therapy of blood sampling. may be used following initial placement of the device in the vein, an injection of a medication or after withdrawal of blood for laboratory analysis.

ישראל - עברית - Ministry of Health

neopharm (israel) 1996 ltd - heparin sodium 200 iu / 100 ml - solution for injection - heparin - as an anticoagulant in extracorporeal circulation, dialysis procedures, and as an aid in the maintenance of catheter patency.

ישראל - עברית - Ministry of Health

sanofi - aventis israel ltd - enoxaparin sodium 100 mg/ml - solution for injection - enoxaparin - treatment of acute st-segment elevation myocardial infarction, in combination with a thrombolytic agent in patients eligible or not for subsequent coronary angioplasty.

ישראל - עברית - Ministry of Health

glaxo smith kline (israel) ltd - nadroparin calcium 3800 iu / 0.4 ml - solution for injection - nadroparin - prophylactic treatment of venous thromboembolic disease during surgery for patients presenting with moderate or high risk. treatment of constituted deep vein thrombosis. prevention of coagulation in the extra corporeal circuit during heamodialysis. the prophylaxis of thromboembolic disorders in high risk medical patients (respiratory failure and/or respiratory infection and/or cardiac failure) hospitalised in intensive care unit.

ישראל - עברית - Ministry of Health

glaxo smith kline (israel) ltd - nadroparin calcium 2850 iu / 0.3 ml - solution for injection - nadroparin - prophylactic treatment of venous thromboembolic disease during surgery for patients presenting with moderate or high risk. treatment of constituted deep vein thrombosis. prevention of coagulation in the extra corporeal circuit during haemodialysis. the prophylaxis of thromboembolic disorders in high risk medical patients (respiratory failure and/or respiratory infection and/or cardiac failure) hospitalised in intensive care unit.

ישראל - עברית - Ministry of Health

glaxo smith kline (israel) ltd - nadroparin calcium 5700 iu / 0.6 ml - solution for injection - nadroparin - prophylactic treatment of venous thromboembolic disease during surgery for patients presenting with moderate or high risk. treatment of constituted deep vein thrombosis. prevention of coagulation in the extra corporeal circuit during haemodialysis. the prophylaxis of thromboembolic disorders in high risk medical patients (respiratory failure and/or respiratory infection and/or cardiac failure) hospitalised in intensive care unit.

ישראל - עברית - Ministry of Health

glaxo smith kline (israel) ltd - nadroparin calcium 7600 iu / 0.8 ml - solution for injection - nadroparin - prophylactic treatment of venous thromboembolic disease during surgery for patients presenting with moderate or high risk. treatment of constituted deep vein thrombosis. prevention of coagulation in the extra corporeal circuit during haemodialysis. the prophylaxis of thromboembolic disorders in high risk medical patients (respiratory failure and/or respiratory infection and/or cardiac failure) hospitalised in intensive care unit.